title: National guidelines, clinical trials, and quality of evidence.
authors.affiliation: Cardiovascular Medical Center, Harbor View Medical Center, 1730 Minor Ave, Suite 1360, Box 358080, Seattle, WA 98101, USA.
authors.forename: B M
authors.initials: BM
authors.lastname: Psaty
authors.forename: C D
authors.initials: CD
authors.lastname: Furberg
authors.forename: M
authors.initials: M
authors.lastname: Pahor
authors.forename: M
authors.initials: M
authors.lastname: Alderman
authors.forename: L H
authors.initials: LH
authors.lastname: Kuller
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002216:Captopril / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D009203:Myocardial Infarction / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D006113:United Kingdom; D014481:United States
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002216:Captopril